|
| ZIOPHARM Receives FDA Orphan Drug Designation for Palifosfamide (ZIO-201) in the Treatment of Soft Tissue Sarcoma |
9 May 08, 11:00 |
|
| NEW YORK----ZIOPHARM Oncology, Inc. , announced today that the United States Food & Drug Administration has granted Orphan Drug Designation to palifosfamide in the treatment of Soft Tissue Sarcoma . |
| more |
|
